Six Firms Steer Five IPO Launches That Could Raise $501M

Law360 (July 13, 2020, 5:47 PM EDT) -- Five biotechnology and medical device companies on Monday joined a packed schedule of initial public offerings, setting price ranges on IPOs estimated to raise a combined $501 million this week, guided by six law firms.

The five offerings are set to price this week, according to IPO research firm Renaissance Capital. If all five companies go public as expected, they will join four additional operating companies in this week's queue, continuing a speedy pace of IPOs in recent weeks.

When counting representation of issuers and underwriters, six law firms are guiding the latest batch of five offerings, including three each by Cooley...

Stay ahead of the curve

In the legal profession, information is the key to success. You have to know what’s happening with clients, competitors, practice areas, and industries. Law360 provides the intelligence you need to remain an expert and beat the competition.


  • Access to case data within articles (numbers, filings, courts, nature of suit, and more.)
  • Access to attached documents such as briefs, petitions, complaints, decisions, motions, etc.
  • Create custom alerts for specific article and case topics and so much more!

TRY LAW360 FREE FOR SEVEN DAYS

Hello! I'm Law360's automated support bot.

How can I help you today?

For example, you can type:
  • I forgot my password
  • I took a free trial but didn't get a verification email
  • How do I sign up for a newsletter?
Beta
Ask a question!